(BIOSPECTRUM) Saskia Kendall unravels concerns around global COVID-19 vaccination programme roll-outs
From 230 vaccine candidates, seven COVID-19 vaccines are being used in at least one country, three of which have been developed in Asia. The unquestionable scientific achievements are now giving way to the challenging logistical and human task of worldwide vaccination programmes.
As new strains of COVID-19 develop and spread, intense interest in the roll-out will only heighten. This situation comes with reputational opportunities and risks for the pharmaceutical industry, and much will hinge on how well roll-outs are managed and the effectiveness of the communication around them.